BEAM THERAPEUTICS INC (BEAM)

US07373V1052 - Common Stock

23.24  +0.52 (+2.29%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
377.71M60.92M51.84M20.00K20.00K
Minority Interest Expense
N/AN/AN/AN/A0.00
Operating Expenses
554.19M399.40M444.31M132.78M75.17M
Research and Development
437.38M311.59M387.09M103.18M54.62M
Selling, General, and Administrative Expenses
116.81M87.81M57.22M29.61M20.55M
Operating Income
-176.49M-338.48M-392.47M-132.76M-75.15M
Interest Income/Expense
35.58M59.40M-1.01M-61.83M-3.10M
Other Income/Expense
9.74M18.90M22.84MN/A-70.00K
Income Before Taxes
-131.16M-260.18M-370.64M-194.59M-78.33M
Income Tax
1.37M3.41MN/AN/AN/A
Net Income
-132.53M-289.09M-370.64M-195.87M-91.04M
EBITDA
-156.47M-324.33M-385.02M-128.02M-71.65M
 
Per Share Data
EPS Diluted Total Ops
-1.72-4.13-5.77-4.19-2.01
Non GAAP EPS
-1.90-4.13-5.94-4.10N/A
 
Statistics
Profit Margin
-35.09%-474.54%-714.97%-979350.00%-455200.00%
Operating Profit Margin
-46.73%-555.61%-757.08%-663800.00%-375750.00%

All data in USD

Charts